Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
  • Alerts
  • Podcasts
  • Subscriptions

Tuberculosis prevention must integrate technological and basic care innovation

Heidi Albert, Ruvandhi R. Nathavitharana, Claudia M. Denkinger, Chris Isaacs, Catharina C. Boehme
European Respiratory Journal 2016 48: 1531-1532; DOI: 10.1183/13993003.01601-2016
Heidi Albert
Foundation for Innovative New Diagnostics, Cape Town, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: heidi.albert@finddx.org
Ruvandhi R. Nathavitharana
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia M. Denkinger
Foundation for Innovative New Diagnostics, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Isaacs
Foundation for Innovative New Diagnostics, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catharina C. Boehme
Foundation for Innovative New Diagnostics, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Complementary innovations in patient support and technology solutions are needed to end TB http://ow.ly/aUrC304opl8

From the authors:

P.H. Mason and colleagues highlight the fact that “new technology alone cannot solve the [tuberculosis] epidemic” and that integrated and community-driven solutions are needed to meet tuberculosis (TB) care and treatment goals. The authors highlight an example of community-wide screening using portable radiography in the pre-antibiotic treatment era, with patients being prescribed rest, diet, exercise and fresh air, leading to a reduction in TB prevalence in the intervention area. We concur with the authors' view that a focus purely on introducing new technologies, be they diagnostics, drugs or vaccines, will not have the desired impact on patient outcomes or public health. In our article, we put forward the proposition that a holistic solution is needed to ensure adequate impact of new diagnostics on patient-important outcomes [1]. For TB patients, especially those with multidrug-resistant disease, who require extremely long and arduous treatment regimens, social support, adequate diet and management of other pre-existing conditions, are essential components of a patient's care, without which patients are unlikely to be successfully treated.

This view is also clearly reflected in the World Health Organization (WHO) End TB strategy [2] pillars: 1) integrated care and prevention (which includes treatment of comorbidities), 2) bold policies and support systems (including social protection, poverty alleviation and actions on other determinants of TB), and 3) intensified research and innovation. Importantly, intensified research and innovation encompasses development of new technologies including drugs, vaccines and diagnostics, but also innovations in implementation to optimise impact. Indeed, the WHO End TB strategy targets for decline in global TB incidence rely on the introduction of new tools, including a point-of-care test for active TB and latent TB infection, by 2025, without which global targets will remain unmet [2].

However, the continued focus on development of new tools should be matched by an equally vigorous drive towards innovation in implementation, with a strong focus on providing patient-centred care. Implementation research must address how novel diagnostics can be better integrated into healthcare systems. We would contend that innovation in patient care and technology-driven solutions need not be mutually exclusive. Many examples describing the use of technology, particularly “electronic health”, in supporting patients during care and treatment exist [3], and we would advocate for combining the benefits of new technologies with an increased awareness of the importance of social and lifestyle factors in patient management. Finally, the example of the chest radiography screening programme provided by P.H. Mason and colleagues also highlights the fact that appropriate patient management, whether treatment, dietary interventions or social support, requires accurate and timely diagnosis as an essential first step.

Footnotes

  • Conflict of interest: None declared.

  • Received August 11, 2016.
  • Accepted August 15, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Albert H,
    2. Nathavitharana RR,
    3. Isaacs C, et al.
    Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J 2016; 48: 516–525.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    World Health Organization. The End TB Strategy. WHO/HTM/TB. www.who.int/tb/post2015_strategy/en/ Date last updated: 2015.
  3. ↵
    1. Falzon D,
    2. Raviglione M,
    3. Bel EH, et al.
    The role of eHealth and mHealth in tuberculosis and tobacco control: a WHO/ERS consultation. Eur Respir J 2015; 46: 307–311.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 5 Table of Contents
European Respiratory Journal: 48 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tuberculosis prevention must integrate technological and basic care innovation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Tuberculosis prevention must integrate technological and basic care innovation
Heidi Albert, Ruvandhi R. Nathavitharana, Claudia M. Denkinger, Chris Isaacs, Catharina C. Boehme
European Respiratory Journal Nov 2016, 48 (5) 1531-1532; DOI: 10.1183/13993003.01601-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Tuberculosis prevention must integrate technological and basic care innovation
Heidi Albert, Ruvandhi R. Nathavitharana, Claudia M. Denkinger, Chris Isaacs, Catharina C. Boehme
European Respiratory Journal Nov 2016, 48 (5) 1531-1532; DOI: 10.1183/13993003.01601-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • The potential impact of azithromycin in IPF
  • Idiopathic interstitial pneumonia or pneumonitis?
  • Idiopathic interstitial pneumonia or pneumonitis?
Show more Agora

Correspondence

  • Idiopathic interstitial pneumonia or pneumonitis?
  • Idiopathic interstitial pneumonia or pneumonitis?
  • Cardio-protective effects of ICS-containing therapy in COPD
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Collections
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2019 by the European Respiratory Society